2022 WHO 指南:成人高血压药物治疗(总结)

2022-06-14 世界卫生组织 WHO

每年死于心血管疾病的人数比死于其他任何原因的人数都多。超过四分之三的心脏病和中风相关死亡发生在低收入和中等收入国家。高血压 - 或血压升高 - 是一种严重的医疗状况,会显着增加患心脏、大脑、肾脏和其他

中文标题:

2022 WHO 指南:成人高血压药物治疗(总结)

发布机构:

世界卫生组织

发布日期:

2022-06-14

简要介绍:

每年死于心血管疾病的人数比死于其他任何原因的人数都多。超过四分之三的心脏病和中风相关死亡发生在低收入和中等收入国家。高血压 - 或血压升高 - 是一种严重的医疗状况,会显着增加患心脏、大脑、肾脏和其他疾病的风险。可以使用特定的收缩压和舒张压水平或报告的抗高血压药物使用来定义高血压。全世界估计有 14 亿人患有高血压,但只有 14% 的人得到了控制。但是,确实存在具有成本效益的治疗方案。在本指南中,世界卫生组织 (WHO) 就开始使用药物治疗成人高血压提供了最新和相关的循证全球公共卫生指南。这些建议针对被适当诊断患有高血压并就生活方式改变提供咨询的成年非怀孕患者。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 WHO 指南:成人高血压药物治疗(总结).pdf)] GetToolGuiderByIdResponse(projectId=1, id=e9db11c002ae863b, title=2022 WHO 指南:成人高血压药物治疗(总结), enTitle=, guiderFrom=WHO, authorId=0, author=, summary=每年死于心血管疾病的人数比死于其他任何原因的人数都多。超过四分之三的心脏病和中风相关死亡发生在低收入和中等收入国家。高血压 - 或血压升高 - 是一种严重的医疗状况,会显着增加患心脏、大脑、肾脏和其他, cover=https://img.medsci.cn/20220625/1656170949059_5579292.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jun 14 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #3c4245;">每年死于心血管疾病的人数比死于其他任何原因的人数都多。</span><span style="color: #3c4245;">超过四分之三的心脏病和中风相关死亡发生在低收入和中等收入国家。</span><span style="color: #3c4245;">高血压 - 或血压升高 - 是一种严重的医疗状况,会显着增加患心脏、大脑、肾脏和其他疾病的风险。</span><span style="color: #3c4245;">可以使用特定的收缩压和舒张压水平或报告的抗高血压药物使用来定义高血压。</span><span style="color: #3c4245;">全世界估计有 14 亿人患有高血压,但只有 14% 的人得到了控制。</span><span style="color: #3c4245;">但是,确实存在具有成本效益的治疗方案。在本指南中,</span><span style="color: #3c4245;">世界卫生组织 (WHO) 就开始使用药物治疗成人高血压提供了最新和相关的循证全球公共卫生指南。</span><span style="color: #3c4245;">这些建议针对被适当诊断患有高血压并就生活方式改变提供咨询的成年非怀孕患者。</span></p>, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7355, appHits=842, showAppHits=0, pcHits=2465, showPcHits=6499, likes=5, shares=79, comments=11, approvalStatus=1, publishedTime=Wed Jun 29 10:27:00 CST 2022, publishedTimeString=2022-06-14, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Jun 25 23:30:35 CST 2022, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 22:08:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 WHO 指南:成人高血压药物治疗(总结).pdf)])
2022 WHO 指南:成人高血压药物治疗(总结).pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2116359, encodeId=33c82116359bd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Fri Feb 24 23:26:26 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099960, encodeId=1ec020999608c, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc38415221, createdName=ms8000001988642695, createdTime=Fri Nov 11 18:26:20 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098415, encodeId=8b0820984150c, content=需要翻译吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63525243343, createdName=147c6666m93(暂无昵称), createdTime=Fri Nov 04 07:04:36 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234753, encodeId=96ac1234e530b, content=是英文的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Tue Jul 26 05:42:01 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233732, encodeId=a99e1233e32f6, content=高血压, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d28118192, createdName=ms3000002046518395, createdTime=Wed Jul 20 23:02:00 CST 2022, time=2022-07-20, status=1, ipAttribution=)]
    2023-02-24 1e1a376dm19(暂无匿称) 来自江苏省

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2116359, encodeId=33c82116359bd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Fri Feb 24 23:26:26 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099960, encodeId=1ec020999608c, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc38415221, createdName=ms8000001988642695, createdTime=Fri Nov 11 18:26:20 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098415, encodeId=8b0820984150c, content=需要翻译吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63525243343, createdName=147c6666m93(暂无昵称), createdTime=Fri Nov 04 07:04:36 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234753, encodeId=96ac1234e530b, content=是英文的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Tue Jul 26 05:42:01 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233732, encodeId=a99e1233e32f6, content=高血压, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d28118192, createdName=ms3000002046518395, createdTime=Wed Jul 20 23:02:00 CST 2022, time=2022-07-20, status=1, ipAttribution=)]
    2022-11-11 ms8000001988642695

    很好👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2116359, encodeId=33c82116359bd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Fri Feb 24 23:26:26 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099960, encodeId=1ec020999608c, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc38415221, createdName=ms8000001988642695, createdTime=Fri Nov 11 18:26:20 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098415, encodeId=8b0820984150c, content=需要翻译吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63525243343, createdName=147c6666m93(暂无昵称), createdTime=Fri Nov 04 07:04:36 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234753, encodeId=96ac1234e530b, content=是英文的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Tue Jul 26 05:42:01 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233732, encodeId=a99e1233e32f6, content=高血压, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d28118192, createdName=ms3000002046518395, createdTime=Wed Jul 20 23:02:00 CST 2022, time=2022-07-20, status=1, ipAttribution=)]
    2022-11-04 147c6666m93(暂无昵称)

    需要翻译吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2116359, encodeId=33c82116359bd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Fri Feb 24 23:26:26 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099960, encodeId=1ec020999608c, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc38415221, createdName=ms8000001988642695, createdTime=Fri Nov 11 18:26:20 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098415, encodeId=8b0820984150c, content=需要翻译吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63525243343, createdName=147c6666m93(暂无昵称), createdTime=Fri Nov 04 07:04:36 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234753, encodeId=96ac1234e530b, content=是英文的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Tue Jul 26 05:42:01 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233732, encodeId=a99e1233e32f6, content=高血压, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d28118192, createdName=ms3000002046518395, createdTime=Wed Jul 20 23:02:00 CST 2022, time=2022-07-20, status=1, ipAttribution=)]
    2022-07-26 ms5000000275821148

    是英文的?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2116359, encodeId=33c82116359bd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Fri Feb 24 23:26:26 CST 2023, time=2023-02-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099960, encodeId=1ec020999608c, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc38415221, createdName=ms8000001988642695, createdTime=Fri Nov 11 18:26:20 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098415, encodeId=8b0820984150c, content=需要翻译吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63525243343, createdName=147c6666m93(暂无昵称), createdTime=Fri Nov 04 07:04:36 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234753, encodeId=96ac1234e530b, content=是英文的?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220718/40f20a20ac39449bb9b54f0a56b3bd59/badab63a8f8940b1aa22f908b6cb9dc4.jpg, createdBy=5b9f6414712, createdName=ms5000000275821148, createdTime=Tue Jul 26 05:42:01 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233732, encodeId=a99e1233e32f6, content=高血压, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56d28118192, createdName=ms3000002046518395, createdTime=Wed Jul 20 23:02:00 CST 2022, time=2022-07-20, status=1, ipAttribution=)]
    2022-07-20 ms3000002046518395

    高血压

    0